US2016152615A1PendingUtilityA1

Prodrugs of substituted azaindoleoxoacetic piperazine derivatives

70
Assignee: BRISTOL MYERS SQUIBB COPriority: Feb 2, 2001Filed: Feb 4, 2016Published: Jun 2, 2016
Est. expiryFeb 2, 2021(expired)· nominal 20-yr term from priority
Inventors:Tao WangZhongxing ZhangNicholas A. MeanwellJohn F. KadowZhiwei YinQiufen XueAlicia Regueiro-RenJohn D. MatiskellaYasutsugu Ueda
A61K 31/496C07D 471/04A61K 45/06A61P 31/12A61P 31/18C07D 491/048
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A prodrug of the compound having the following formula:

Join the waitlist — get patent alerts

Track US2016152615A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.